Low grade papillary transitional cell carcinoma pelvic recurrence masquerading as high grade invasive carcinoma, ten years after radical cystectomy

por Dangle, Pankaj P, Wang, Wenle Paul, Mayerson, Joel, Mortazavi, Amir, Monk, Paul
Publicado 2008

Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid Arthritis

por Hasan, Eman A., Jessop, David S., Power, Lynsey L., Monk, Paul T., Kirwan, John R.
Publicado 2009

Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report

por Johnson, Kai, Issa, Majd, Parikh, Anish, Monk, Paul, Yin, Ming, Mortazavi, Amir, Yang, Yuanquan
Publicado 2021

Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review

por Yaney, Alexander, Stevens, Andrew, Monk, Paul, Martin, Douglas, Diaz, Dayssy A., Wang, Shang-Jui
Publicado 2022

Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high‐risk localized prostate cancer

por Yin, Ming, Zhao, Jing, Monk, Paul, Martin, Douglas, Folefac, Edmund, Joshi, Monika, Jin, Ning, Mortazavi, Amir, Verschraegen, Claire, Clinton, Steven
Publicado 2019

Alterations of DNA damage response genes correlate with response and overall survival in anti‐PD‐1/PD‐L1‐treated advanced urothelial cancer

por Joshi, Monika, Grivas, Petros, Mortazavi, Amir, Monk, Paul, Clinton, Steven K., Sue‐Ann Woo, Michele, Holder, Sheldon L., Drabick, Joseph J., Yin, Ming
Publicado 2020

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

por Monk, Paul, Lam, Elaine, Mortazavi, Amir, Kendra, Kari, Lesinski, Gregory B., Mace, Thomas A., Geyer, Susan, Carson, William E., Tahiri, Sanaa, Bhinder, Arvinder, Clinton, Steven K., Olencki, Thomas
Publicado 2014

Retrospective Analysis of the Safety and Efficacy of High-dose Interleukin-2 After Prior Tyrosine Kinase Inhibitor Therapy in Patients With Advanced Renal Cell Carcinoma

por Lam, Elaine T., Wong, Michael K. K., Agarwal, Neeraj, Redman, Bruce G., Logan, Theodore, Gao, Dexiang, Flaig, Thomas W., Lewis, Karl, Poust, Jamie, Monk, Paul, Jarkowski, Anthony, Sendilnathan, Arun, Bolden, Marcus, Kuzel, Timothy M., Olencki, Thomas
Publicado 2014

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)

por Monk, Paul, Liu, Glenn, Stadler, Walter M., Geyer, Susan, Huang, Ying, Wright, John, Villalona-Calero, Miguel, Wade, James, Szmulewitz, Russell, Gupta, Shilpa, Mortazavi, Amir, Dreicer, Robert, Pili, Roberto, Dawson, Nancy, George, Saby, Garcia, Jorge A.
Publicado 2018

Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial

por Vaishampayan, Ulka N., Heilbrun, Lance K., Monk, Paul, Tejwani, Sheela, Sonpavde, Guru, Hwang, Clara, Smith, Daryn, Jasti, Pallavi, Dobson, Kimberlee, Dickow, Brenda, Heath, Elisabeth I., Semaan, Louie, Cher, Michael L., Fontana, Joseph A., Chinni, Sreenivasa
Publicado 2021

Comparison of the clinical and cost effectiveness of two management strategies (rehabilitation versus surgical reconstruction) for non-acute anterior cruciate ligament (ACL) injury...

por Davies, Loretta, Cook, Jonathan, Leal, Jose, Areia, Carlos Morgado, Shirkey, Beverly, Jackson, William, Campbell, Helen, Fletcher, Heidi, Carr, Andrew, Barker, Karen, Lamb, Sarah E., Monk, Paul, O’Leary, Sean, Haddad, Fares, Wilson, Chris, Price, Andrew, Beard, David
Publicado 2020

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase II...

por Unger, Joseph M., Griffin, Katherine, Donaldson, Gary W., Baranowski, Karen M., Good, Margorie J., Reburiano, Eunicia, Hussain, Maha, Monk, Paul J., Van Veldhuizen, Peter J., Carducci, Michael A., Higano, Celestia S., Lara, Primo N., Tangen, Catherine M., Quinn, David I., Wade, James L., III, Vogelzang, Nicholas J., Thompson, Ian M., Jr, Moinpour, Carol M.
Publicado 2018

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)

por Pachynski, Russell K, Morishima, Chihiro, Szmulewitz, Russell, Harshman, Lauren, Appleman, Leonard, Monk, Paul, Bitting, Rhonda L, Kucuk, Omer, Millard, Frederick, Seigne, John D, Fling, Steven P, Maecker, Holden T, Duault, Caroline, Ramchurren, Nirasha, Hess, Bruce, D’Amico, Leonard, Lacroix, Andreanne, Kaiser, Judith C, Morre, Michel, Grégoire, Anne, Cheever, Martin, Yu, Evan Y, Fong, Lawrence
Publicado 2021

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

por Kim, Joseph W., McKay, Rana R., Radke, Marc R., Zhao, Shilin, Taplin, Mary-Ellen, Davis, Nancy B., Monk, Paul, Appleman, Leonard J., Lara, Primo N., Vaishampayan, Ulka N., Zhang, Jingsong, Paul, Asit K., Bubley, Glenn, Van Allen, Eliezer M., Unlu, Serhan, Huang, Ying, Loda, Massimo, Shapiro, Geoffrey I., Glazer, Peter M., LoRusso, Patricia M., Ivy, S. Percy, Shyr, Yu, Swisher, Elizabeth M., Petrylak, Daniel P.
Publicado 2023

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

por Apolo, Andrea B., Nadal, Rosa, Girardi, Daniel M., Niglio, Scot A., Ley, Lisa, Cordes, Lisa M., Steinberg, Seth M., Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N., Costello, Rene, Trepel, Jane B., Lee, Min-Jung, Merino, Maria J., Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D., Gulley, James L., Agarwal, Piyush K., Valera, Vladimir, Chalfin, Heather J., Jones, Jennifer, Streicher, Howard, Wright, John J., Ning, Yangmin M., Parnes, Howard L., Dahut, William L., Bottaro, Donald P., Lara, Primo N., Saraiya, Biren, Pal, Sumanta K., Stein, Mark N., Mortazavi, Amir
Publicado 2020